Skip to main content
Top
Published in: Neurological Sciences 9/2020

01-09-2020 | Stroke | COVID-19

A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients

Authors: Davide Sangalli, Valeria Polonia, Daniele Colombo, Vittorio Mantero, Marco Filizzolo, Chiara Scaccabarozzi, Andrea Salmaggi

Published in: Neurological Sciences | Issue 9/2020

Login to get access

Abstract

The sudden worldwide outbreak of Coronavirus Disease 2019 (COVID-19) has certainly provided new challenges in the management of acute ischaemic stroke, and the risk-benefit ratio of intravenous thrombolysis in COVID-19 positive patients is not well known. We describe four COVID-19 patients treated with intravenous thrombolysis for acute ischaemic stroke. Although rt-PA administration is the main therapeutic strategy, our patients experienced unpredictable complications and showed atypical features: the overall mortality was very high. In conclusion, in this article, we provide information about these cases and discuss the possible explanation behind this trend.
Literature
1.
go back to reference Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062CrossRef Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062CrossRef
2.
go back to reference Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50:e344–e418CrossRef Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50:e344–e418CrossRef
3.
go back to reference Helsinki Stroke Thrombolysis Registry Group (2013) Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients. Int J Stroke 8:632–638CrossRef Helsinki Stroke Thrombolysis Registry Group (2013) Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients. Int J Stroke 8:632–638CrossRef
4.
go back to reference Co COC, Yu JRT, Laxamana LC, David-Ona DIA (2020) Intravenous thrombolysis for stroke in a COVID-19 positive filipino patient, a case report. J Clin Neurosci:S0967–5868(20)30727-X Co COC, Yu JRT, Laxamana LC, David-Ona DIA (2020) Intravenous thrombolysis for stroke in a COVID-19 positive filipino patient, a case report. J Clin Neurosci:S0967–5868(20)30727-X
7.
go back to reference Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD (2020) Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. Thromb Haemost 18:1752–1755. https://doi.org/10.1111/jth.14828CrossRef Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD (2020) Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. Thromb Haemost 18:1752–1755. https://​doi.​org/​10.​1111/​jth.​14828CrossRef
Metadata
Title
A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients
Authors
Davide Sangalli
Valeria Polonia
Daniele Colombo
Vittorio Mantero
Marco Filizzolo
Chiara Scaccabarozzi
Andrea Salmaggi
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 9/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04591-3

Other articles of this Issue 9/2020

Neurological Sciences 9/2020 Go to the issue